This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Friday's Small-Cap Winners & Losers

DG FastChannel (DGIT) rose after it priced a public offering of about 2.96 million shares at $11.40 each. A stockholder is selling 400,000 shares, and the company is offering the rest. DG was rising 6.5% to $12.25.

Immunicon (IMMC) jumped on word that Veridex, a Johnson & Johnson (JNJ - Get Report) company, received U.S. regulatory clearance for the CellSearch Circulating Tumor Cell Kit as an aid in the monitoring of patients with metastatic breast cancer. The product is made by Immunicon and distributed by Veridex. Shares were surging 38.5% to $3.67.

Isilon Systems (ISLN) was soaring in its debut after pricing its initial public offering of 8.35 million shares at $13 each. Lately the stock was up $9.85, or 76%, at $22.85.

netGuru (NGRUD) got a boost after saying its board approved a 1-for-15 reverse split in anticipation of its reverse merger with privately held BPO Management Services. The board also declared a dividend that will amount to about $2.73 on each post-split share. netGuru was climbing 44.5% to $4.77.

Affymax (AFFY) was gaining nearly 31% following its initial public offering of 3.7 million shares. The stock was priced at $25 a share. Lately, Affymax was up $7.69 to $32.69.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DGIT $12.07 -0.33%
AFFY $0.14 -1.69%
CNLG $0.02 -20.00%
AXTI $2.77 1.09%
JNJ $101.65 -0.67%


DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs